Study of Artesunate in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Locally Advanced Breast Cancer
Interventions: DRUG: artesunate
Sponsor: Heidelberg University
Collaborators: Hector-Stiftung|Dafra Pharma|Monika-Kutzner Stiftung, Berlin, Germany|HEIFAN-Heidelberger Förderverein d. Ambulanz f. Naturheilkunde eV, Heidelberg, Germany